Trial Identifier: | D8220C00022 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04930536 |
Start Date: | July 2021 |
Primary Completion Date: | May 2023 |
Study Completion Date: | May 2023 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.